Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente  Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,
Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Lilia Cervantes, Monica Grafals, Rudolph A. Rodriguez 
Evaluation of Kidney Donors: Core Curriculum 2018
Peritoneal dialysis American Journal of Kidney Diseases
Uric Acid as a Target of Therapy in CKD
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Filtration Markers in Acute Kidney Injury
Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc 
Metabolic Complications in Elderly Adults With CKD
Development of Reduced Kidney Function in Rheumatoid Arthritis
Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H
Care of the Undocumented Immigrant in the United States With ESRD
Francesca Mallamaci, MD, Giovanni Tripepi, PhD 
Empirically Derived Search Filters for the Development of Kidney Disease Clinical Practice Guidelines  Pavel S. Roshanov, MD, MSc, Arthur V. Iansavichus,
A Decade After the KDOQI CKD Guidelines
Matei Neagu, PhD, Daniel Coca, PhD, Albert C.M. Ong, DM 
Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP) 
What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes?  Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,
Quiz Page July 2009 American Journal of Kidney Diseases
Improving Carboplatin Dosing Based on Estimated GFR
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
Evaluation of the Potential Living Kidney Donor
Kidney Tattoos American Journal of Kidney Diseases
Your Kidneys May Outlive You
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Salt and Hypertension American Journal of Kidney Diseases
Acute Kidney Injury and CKD: Chicken or Egg?
Karl D. Nolph, MD, American Journal of Kidney Diseases
End-stage renal disease in living kidney donors
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Assessment of Glomerular Filtration Rate and End-Stage Kidney Disease Risk in Living Kidney Donor Candidates: A Paradigm for Evaluation, Selection, and.
GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta- analysis of Treatment Effects From 37 Randomized Trials  Lesley A.
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
A Decade After the KDOQI CKD Guidelines: A Historical Perspective
GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials  Hiddo J. Lambers Heerspink, PhD, Hocine.
Prediabetes as a Precursor to Diabetic Kidney Disease
Julie A. Wright Nunes, MD, MPH, Kerri L
Quiz Page July 2012 American Journal of Kidney Diseases
Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies  Krista L. Lentine, MD, MS, Frank P. Hurst,
Polyunsaturated Fatty Acids and Kidney Disease
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
Nephrology: As It Was Then, But Is Not Now
Performance of GFR Estimating Equations Stratified by Measured or Estimated GFR: Implications for Interpretation  Jonas Björk, PhD, Anders Grubb, MD,
Beef Tea, Vitality, Creatinine, and the Estimated GFR
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Evidence and Outcomes in CKD
Within-Person Variability in Kidney Measures
Drug Dose Adjustments in Patients With Renal Impairment
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Methods for guideline development
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Improving Carboplatin Dosing Based on Estimated GFR
Arnold S. Relman, MD, American Journal of Kidney Diseases
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Trial Quality in Nephrology: How Are We Measuring Up?
Removal of Dabigatran by Hemodialysis
Was It the Nephrologists or the Fluid?
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
Patient Safety Issues in CKD: Core Curriculum 2015
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Dialysis Research and N-of-1 Trials: Made for Each Other?
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary  Peter A. McCullough, MD, MPH, Joseph A.
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Presentation transcript:

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD, Amit X. Garg, MD, PhD  American Journal of Kidney Diseases  Volume 72, Issue 1, Pages 154-155 (July 2018) DOI: 10.1053/j.ajkd.2018.01.059 Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Schematic for the application of glomerular filtration rate (GFR) to living donor candidacy determination. Reproduced from Levey and Inker5 with permission from the American Society of Nephrology. GFR values expressed in mL/min/1.73 m2. Abbreviations: eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; mGFR, measured glomerular filtration rate. American Journal of Kidney Diseases 2018 72, 154-155DOI: (10.1053/j.ajkd.2018.01.059) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions